Literature DB >> 14968086

[Visudyne photodynamic therapy and feeder vessel occlusion: rationale of a synergistic association and clinical options].

M Sickenberg1, J P Ballini, H van den Bergh.   

Abstract

PURPOSE: Visudyne photodynamic therapy (PDT) has provided considerable improvement in patient care of subfoveal choroidal neovascularization (CNV). Patients tend to loose vision for a few months after the initial treatment, but the 4-year proven stability in vision most often provides an acceptable quality of life, sometimes with additional low vision rehabilitation. The initial visual acuity loss, borderline cost-effectiveness, and subgroups of patients not responding to PDT warrant improving the symptomatic treatment of subfoveal CNV. Today, the most tempting solution would be to combine PDT with an occlusion of the feeder vessel (FV).
METHODS: Two patients are described in whom the feeder vessel was occluded using modifications of the classic PDT treatment method. The FV was identified in both patients using fluorescein and indocyanine green angiographies at a recorded video rate using a modified scanning laser ophthalmoscope (Rodenstock SLO). The feeder vessel of the first patient was occluded by minimal photocoagulation immediately after a Visudyne PDT treatment in order to take advantage of the reduced blood flow within the feeder vessel. The second patient presenting a subfoveal FV was treated using a modified PDT treatment called feeder-vessel PDT. The photosensitizing agent was activated by a first classic spot covering the lesion, followed immediately by a small spot focused on the feeder vessel.
RESULTS: Both subfoveal CNVs were successfully and selectively occluded and some visual acuity was gained following the treatment.
CONCLUSION: Occlusion of the feeder vessel is an appealing clinical option that is complementary to Visudyne PDT. Both treatment methods presented here could provide additional options to close subfoveal CNV with an optimal efficacy-risk ratio.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14968086     DOI: 10.1016/s0181-5512(04)96100-1

Source DB:  PubMed          Journal:  J Fr Ophtalmol        ISSN: 0181-5512            Impact factor:   0.818


  3 in total

1.  Phase I clinical trial results of verteporfin enhanced feeder vessel therapy in subfoveal choroidal neovascularisation in age related macular degeneration.

Authors:  I Kozak; L Cheng; D E Cochran; W R Freeman
Journal:  Br J Ophthalmol       Date:  2006-06-14       Impact factor: 4.638

2.  Photodynamic therapy of choroidal neovascularization with enlargement of the spot size to include the feeding complex.

Authors:  Ilias Georgalas; Alexandros A Rouvas; Dimitrios A Karagiannis; Athanasios I Kotsolis; Ioannis D Ladas
Journal:  Clin Ophthalmol       Date:  2009-06-02

3.  Video monitoring of neovessel occlusion induced by photodynamic therapy with verteporfin (Visudyne), in the CAM model.

Authors:  E Debefve; B Pegaz; H van den Bergh; G Wagnières; N Lange; J-P Ballini
Journal:  Angiogenesis       Date:  2008-03-07       Impact factor: 9.596

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.